D. Marriott

发表

Leishmaniasis, an emerging imported infection: report of 20 cases from Australia.

D. Stark, S. V. van Hal, Rogan Lee, 2008, Journal of travel medicine.

Managing antituberculosis drug therapy by therapeutic drug monitoring of rifampicin and isoniazid

D. Marriott, J. Ray, I. Gardiner, 2003, Internal medicine journal.

Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients

D. Marriott, T. Sorrell, W. Meyer, 2009, Pediatrics.

Active Surveillance of Candidemia, Australia

D. Marriott, T. Sorrell, D. Ellis, 2006, Emerging infectious diseases.

Candida dubliniensis candidemia in Australia.

D. Marriott, J. Harkness, M. Laxton, 2001, Emerging infectious diseases.

Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents

D. Marriott, D. Paterson, A. MacGowan, 2020, Clinical Pharmacokinetics.

Importance of Nonenteric Protozoan Infections in Immunocompromised People

D. Stark, D. Marriott, J. Harkness, 2010, Clinical Microbiology Reviews.

Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

D. Marriott, D. Cattaneo, S. Baldelli, 2021, Therapeutic drug monitoring.

Methicillin-Resistant Staphylococcus aureus (MRSA) Detection: Comparison of Two Molecular Methods (IDI-MRSA PCR Assay and GenoType MRSA Direct PCR Assay) with Three Selective MRSA Agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for Use with Infection-Control Swabs

D. Stark, D. Marriott, J. Harkness, 2007, Journal of Clinical Microbiology.

Epidemic Strains of Shigella sonnei Biotype g Carrying Integrons

D. Marriott, J. Harkness, P. White, 2002, Journal of Clinical Microbiology.

Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections

D. Marriott, A. Patanwala, S. Heysell, 2021, Clinical Pharmacokinetics.

Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp.

D. Marriott, T. Sorrell, D. Ellis, 2008, Critical care medicine.

Detection of Dientamoeba fragilis in fresh stool specimens using PCR.

N. Beebe, D. Stark, D. Marriott, 2005, International journal for parasitology.

Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices

M. Baysari, R. Day, D. Marriott, 2021, British journal of clinical pharmacology.

Detection of Dientamoeba fragilis in animal faeces using species specific real time PCR assay.

D. Stark, D. Marriott, J. Harkness, 2016, Veterinary parasitology.

Common Infections Following Lung Transplantation

D. Marriott, C. Morrissey, Deborah Marriott, 2018, Essentials in Lung Transplantation.

Clinico-pathological study of cytomegalovirus (CMV) in AIDS autopsies: under-recognition of CMV pneumonitis and CMV adrenalitis.

D. Marriott, G. Dore, Johan Duflou, 1995, Australian and New Zealand journal of medicine.

Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring

R. Day, D. Marriott, I. Sandaradura, 2020, Antimicrobial Agents and Chemotherapy.

An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy

R. Day, D. Marriott, H. Buscher, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Impact of Therapeutic Drug Monitoring of Antiretroviral Drugs in Routine Clinical Management of People Living with HIV: a narrative review.

E. Clementi, D. Marriott, D. Cattaneo, 2020, Therapeutic drug monitoring.

Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS

D. Cooper, D. Marriott, B. Brew, 1992, Annals of Internal Medicine.

Clinical Significance of Enteric Protozoa in the Immunosuppressed Human Population

D. Stark, S. V. van Hal, D. Marriott, 2009, Clinical Microbiology Reviews.

Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART.

D. Marriott, M. Bloch, A. Carr, 2016, The Journal of antimicrobial chemotherapy.

Cluster of invasive Mycobacteria chimaera infections following cardiac surgery demonstrating novel clinical features and risks of aortic valve replacement

D. Marriott, V. Sintchenko, A. Hofmeyr, 2018, Internal medicine journal.

Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics.

D. Marriott, M. Neely, D. Cattaneo, 2020, Therapeutic drug monitoring.

Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapy

A. Winston, D. Cooper, D. Marriott, 2006, HIV medicine.

MRSA detection: comparison of two molecular methods (BD GeneOhm® PCR assay and Easy-Plex) with two selective MRSA agars (MRSA-ID and Oxoid MRSA) for nasal swabs

D. Stark, D. Marriott, J. Harkness, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

Donor‐derived tuberculosis (TB): isoniazid‐resistant TB transmitted from a lung transplant donor with inadequately treated latent infection

D. Marriott, D. Darley, E. Goeman, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Enterococcus cecorum infective endocarditis in a patient with chronic myeloid leukemia and cirrhosis.

D. Marriott, Hannah Hsu, Vincent Seah, 2021, Pathology.

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

K. Byth, D. Marriott, T. Sorrell, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients

D. Marriott, J. Kosterink, J. Zijlstra, 2020, Antimicrobial Agents and Chemotherapy.

Current treatment options for Dientamoeba fragilis infections.

D. Stark, D. Marriott, J. Harkness, 2012, International journal for parasitology. Drugs and drug resistance.

Epidemiology: surveillance of fungal infections.

D. Marriott, R. Barton, W. Meyer, 2000, Medical mycology.

Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection.

D. Marriott, B. Brew, M. Law, 1996, Journal of neurology, neurosurgery, and psychiatry.

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014

D. Marriott, J. Roberts, C. Cooper, 2014, Internal medicine journal.

Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders

D. Marriott, C. Blyth, J. Ray, 2008, Internal medicine journal.

Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole.

D. Marriott, G. Dore, J. Harkness, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients

R. Day, D. Marriott, K. Williams, 2013, Therapeutic drug monitoring.

Characterization of recombinant tetanus toxin derivatives suitable for vaccine development

N. Fairweather, G. Dougan, D. Marriott, 1995, Infection and immunity.

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy

D. Marriott, A. McLachlan, J. Alffenaar, 2018, Drugs & Aging.

Candida dubliniensis Meningitis as Delayed Sequela of Treated C. dubliniensis Fungemia

D. Stark, S. V. van Hal, D. Marriott, 2008, Emerging infectious diseases.

The Prevalence of Angiostrongylus cantonensis/mackerrasae Complex in Molluscs from the Sydney Region

D. Stark, Rogan Lee, D. Marriott, 2015, PloS one.

Determinants of mortality in non-neutropenic ICU patients with candidaemia

D. Marriott, T. Sorrell, D. Ellis, 2009, Critical care.

Skeletal Muscle Toxicity Associated With Raltegravir-Based Combination Antiretroviral Therapy in HIV-Infected Adults

D. Marriott, J. Amin, S. Pett, 2013, Journal of acquired immune deficiency syndromes.

Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.

D. Marriott, T. Sorrell, V. Sintchenko, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Oral ribavirin for respiratory syncytial virus infection after lung transplantation: Efficacy and cost-efficiency.

D. Marriott, A. Havryk, A. Glanville, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Veillonella parvula Discitis and Secondary Bacteremia: a Rare Infection Complicating Endoscopy and Colonoscopy?

D. Stark, D. Marriott, J. Harkness, 2006, Journal of Clinical Microbiology.

Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic.

D. Marriott, A. McLachlan, M. Bloch, 2005, British journal of clinical pharmacology.

Mycoses in AIDS Patients

D. Marriott, D. Denning, T. Sirisanthana, 2011, Springer US.

Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.

D. Stark, S. V. van Hal, D. Marriott, 2007, International journal for parasitology.

Absence of human Bocavirus in bronchoalveolar lavage fluid of lung transplant patients.

D. Stark, D. Marriott, J. Harkness, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii.

K. Byth, D. Marriott, W. J. McBride, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Voriconazole concentrations and outcome of invasive fungal infections.

D. Marriott, S. Miyakis, J. Ray, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Use of the ELISpot assay to detect abacavir- and nevirapine-induced IFN-g responses in PBMC from HIV-infected patients with abacavir or nevirapine hypersensitivity reactions

S. Mallal, D. Marriott, A. Kelleher, 2007 .

Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring

D. Marriott, A. McLachlan, J. Ray, 2012, Antimicrobial Agents and Chemotherapy.

Anncaliia algerae Microsporidial Myositis

D. Stark, D. Marriott, S. Brammah, 2014, Emerging infectious diseases.

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

D. Marriott, J. Timsit, M. Neely, 2020, Intensive Care Medicine.

A Model Averaging/Selection Approach Improves the Predictive Performance of Model‐Informed Precision Dosing: Vancomycin as a Case Study

David W. Uster, Sophie L. Stocker, Jane E. Carland, 2020, Clinical pharmacology and therapeutics.

Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen

D. Stark, Rogan Lee, D. Marriott, 2016, Parasitology.

Amoebiasis: current status in Australia

D. Stark, D. Marriott, J. Ellis, 2007, The Medical journal of Australia.

Scytalidium dimidiatum and Lecythophora hoffmannii: unusual causes of fungal infections in a patient with AIDS

D. Cooper, D. Marriott, K. Wong, 1997, Journal of clinical microbiology.

Disseminated histoplasmosis in an AIDS patient.

D. Marriott, T. Gottlieb, 1990, Australian and New Zealand journal of medicine.

Antifungal susceptibilities of non-Aspergillus filamentous fungi causing invasive infection in Australia: support for current antifungal guideline recommendations.

S. V. van Hal, D. Marriott, T. Sorrell, 2016, International journal of antimicrobial agents.

Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death.

Wieland Meyer, Tania C Sorrell, Karen Byth, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An Evaluation Of Four Methods For The Detection Of Pneumocystis Carinii In Clinical Specimens

D. Marriott, J. Harkness, S. Tiley, 1994, Pathology.

CRYPTOSPORIDIOSIS IN THE ACQUIRED IMMUNE DEFICIENCY SYNDROME

D. Marriott, R. Penny, J. Harkness, 1984, Pathology.

A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients.

D. Marriott, J. Penm, D. Andresen, 2019, The Journal of antimicrobial chemotherapy.

Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV‐infected patients: A double‐blind placebo‐controlled study

D. Marriott, J. Hoy, J. Harkness, 1993, The Medical journal of Australia.

Laboratory Diagnostic Techniques for Entamoeba Species

D. Marriott, N. Beebe, D. Stark, 2007, Clinical Microbiology Reviews.

Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality.

D. Marriott, T. Sorrell, W. Meyer, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prototheca wickerhamii Mimicking Yeast: a Cautionary Tale

D. Stark, D. Marriott, B. McMullan, 2011, Journal of Clinical Microbiology.

Emerging therapeutic drug monitoring of anti‐infective agents in Australian hospitals: Availability, performance and barriers to implementation

R. Day, D. Marriott, J. Roberts, 2021, British journal of clinical pharmacology.

Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course.

D. Stark, D. Marriott, J. Harkness, 2007, Journal of medical microbiology.

Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.

D. Marriott, T. Sorrell, W. Meyer, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Microsporidial keratoconjunctivitis in AIDS

D. Marriott, A. Field, P. McCluskey, 1993, Eye.

Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy

D. Cooper, D. Marriott, E. Vasak, 1998, The Lancet.

Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS

D. Marriott, B. Brew, E. Canning, 1996, Journal of clinical microbiology.

Limited genetic diversity among genotypes of Enterocytozoon bieneusi strains isolated from HIV-infected patients from Sydney, Australia.

D. Stark, S. V. van Hal, D. Marriott, 2009, Journal of medical microbiology.

Declining incidence of intestinal microsporidiosis and reduction in AIDS-related mortality following introduction of HAART in Sydney, Australia.

D. Stark, D. Marriott, J. Harkness, 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Development and ultrastructure of Trachipleistophora hominis n.g., n.sp. after in vitro isolation from an AIDS patient and inoculation into athymic mice

D. Marriott, E. Canning, J. Kench, 1996, Parasitology.

Activity of benzimidazoles against Dientamoeba fragilis (Trichomonadida, Monocercomonadidae) in vitro and correlation of beta-tubulin sequences as an indicator of resistance

D. Stark, D. Marriott, J. Harkness, 2014, Parasite.

Mucormycosis in Australia: contemporary epidemiology and outcomes.

D. Marriott, T. Sorrell, W. Meyer, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.

D. Marriott, T. Sorrell, D. Ellis, 2010, The Journal of antimicrobial chemotherapy.

Posaconazole Plasma Concentrations in Critically Ill Patients

D. Marriott, J. Ray, Q. Nguyen, 2011, Therapeutic drug monitoring.

Concomitant marked decline in prevalence of SARS-CoV-2 and other respiratory viruses among symptomatic patients following public health interventions in Australia: data from St Vincent’s Hospital and associated screening clinics, Sydney, NSW.

D. Stark, D. Marriott, J. Harkness, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Miliary pulmonary cryptococcosis

D. Marriott, S. Kelly, 2014, Medical mycology case reports.

Achromobacter xylosoxidans subsp. xylosoxidans prosthetic aortic valve infective endocarditis and aortic root abscesses.

D. Stark, D. Marriott, J. Harkness, 2008, Journal of medical microbiology.

Microsporidia in the small intestine of HIV‐infected patients: A new diagnostic technique and a new species

D. Marriott, S. Milliken, A. Field, 1993, The Medical journal of Australia.

The Warthin-Starry stain in the diagnosis of small intestinal microsporidiosis in HIV-infected patients.

D. Marriott, A. Field, M. Hing, 1993, Folia parasitologica.

Prevalence of enteric protozoa in human immunodeficiency virus (HIV)-positive and HIV-negative men who have sex with men from Sydney, Australia.

N. Beebe, D. Stark, S. V. van Hal, 2007, The American journal of tropical medicine and hygiene.

Prospective Study of the Prevalence, Genotyping, and Clinical Relevance of Dientamoeba fragilis Infections in an Australian Population

N. Beebe, D. Stark, D. Marriott, 2005, Journal of Clinical Microbiology.

Bile acid malabsorption in HIV infected patients with chronic diarrhoea.

D. Cooper, D. Marriott, J. Freund, 1996, Australian and New Zealand journal of medicine.

Further observations on the ultrastructure of Septata intestinalis Cali, Kotler and Orenstein, 1993

D. Marriott, E. Canning, A. Field, 1994 .

Gastrointestinal Viral Infections in Homosexual Men Who were Symptomatic and Seropositive for Human Immunodeficiency Virus

D. Cooper, D. Marriott, J. Harkness, 1988, The Journal of infectious diseases.

Dientamoebiasis: clinical importance and recent advances.

N. Beebe, D. Stark, D. Marriott, 2006, Trends in parasitology.

Entamoeba moshkovskii infections in Sydney, Australia

D. Stark, D. Marriott, J. Harkness, 2008, European Journal of Clinical Microbiology & Infectious Diseases.

PCR Detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in Stool Samples from Sydney, Australia

N. Beebe, D. Stark, D. Marriott, 2007, Journal of Clinical Microbiology.

A review of Dientamoeba fragilis carriage in humans: Several reasons why this organism should be considered in the diagnosis of gastrointestinal illness

D. Stark, D. Marriott, J. Harkness, 2011, Gut microbes.

The ambiguous life of Dientamoeba fragilis: the need to investigate current hypotheses on transmission

D. Stark, D. Marriott, J. Harkness, 2011, Parasitology.

Evaluation of Multiplex Tandem Real-Time PCR for Detection of Cryptosporidium spp., Dientamoeba fragilis, Entamoeba histolytica, and Giardia intestinalis in Clinical Stool Samples

D. Stark, D. Marriott, J. Harkness, 2010, Journal of Clinical Microbiology.

A case-controlled study of Dientamoeba fragilis infections in children

D. Stark, D. Marriott, J. Harkness, 2011, Parasitology.

Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples

D. Stark, D. Marriott, J. Harkness, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Gorillas are a host for Dientamoeba fragilis: an update on the life cycle and host distribution.

D. Stark, D. Marriott, J. Harkness, 2008, Veterinary parasitology.

Evaluation of Three Diagnostic Methods, Including Real-Time PCR, for Detection of Dientamoeba fragilis in Stool Specimens

N. Beebe, D. Stark, D. Marriott, 2006, Journal of Clinical Microbiology.

A review of the clinical presentation of dientamoebiasis.

D. Stark, D. Marriott, J. Harkness, 2010, The American journal of tropical medicine and hygiene.

Detection and transmission of Dientamoeba fragilis from environmental and household samples.

D. Stark, D. Marriott, J. Harkness, 2012, The American journal of tropical medicine and hygiene.

In Vitro Susceptibility Testing of Dientamoeba fragilis

D. Stark, D. Marriott, J. Harkness, 2011, Antimicrobial Agents and Chemotherapy.

Newly defined conditions for the in vitro cultivation and cryopreservation of Dientamoeba fragilis: new techniques set to fast track molecular studies on this organism

D. Stark, D. Marriott, J. Harkness, 2010, Parasitology.

Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia

D. Stark, D. Marriott, J. Harkness, 2009, Infectious disease reports.

Evaluation of the EasyScreen™ enteric parasite detection kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples.

D. Stark, D. Marriott, J. Harkness, 2014, Diagnostic microbiology and infectious disease.

Acquired immune deficiency syndrome

D. Marriott, R. Penny, D. Bryant, 1983 .

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.

D. Marriott, T. Sorrell, V. Sintchenko, 2017, Journal of visualized experiments : JoVE.

Clinician Ordering Practices for Voriconazole Therapeutic Drug Monitoring: Experiences of a Referral Laboratory

D. Marriott, S. Miyakis, J. Ray, 2010, Therapeutic drug monitoring.

The management of anti-infective agents in intensive care units: the potential role of a ‘fast’ pharmacology

D. Marriott, D. Cattaneo, A. Corona, 2020, Expert review of clinical pharmacology.

Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.

A. Winston, D. Cooper, D. Marriott, 2005, Journal of Antimicrobial Chemotherapy.

Posaconazole-induced topiramate toxicity.

D. Marriott, J. Ray, R. Lévy, 2009, Annals of internal medicine.

Candida Colonization as a Risk Marker for Invasive Candidiasis in Mixed Medical-Surgical Intensive Care Units: Development and Evaluation of a Simple, Standard Protocol

D. Marriott, T. Sorrell, E. McBryde, 2015, Journal of Clinical Microbiology.

Yersinia enterocolitica infection in children

D. Marriott, D. Dorman, Sharon F. Taylor, 1985, The Medical journal of Australia.

Molecular Epidemiology of Imported Cases of Leishmaniasis in Australia from 2008 to 2014

D. Stark, Rogan Lee, D. Marriott, 2015, PloS one.

Seroprevalence of Entamoeba histolytica infection among men who have sex with men in Sydney, Australia.

D. Stark, D. Marriott, J. Harkness, 2010, The American journal of tropical medicine and hygiene.

Comparison of Stool Antigen Detection Kits to PCR for Diagnosis of Amebiasis

D. Stark, S. V. van Hal, D. Marriott, 2008, Journal of Clinical Microbiology.

Invasive Amebiasis in Men Who Have Sex with Men, Australia

D. Stark, S. V. van Hal, D. Marriott, 2008, Emerging infectious diseases.

Evaluation of the EasyScreen Protozoan Detection Kit for the diagnosis of Entamoeba histolytica.

D. Stark, D. Marriott, J. Harkness, 2019, Pathology.

Treatment failure in patients with chronic Blastocystis infection.

D. Stark, D. Marriott, J. Harkness, 2014, Journal of medical microbiology.

Amoebiasis: current status in Australia

D. Stark, D. Marriott, J. Harkness, 2007 .

Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.

R. Day, D. Marriott, S. Wicha, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.

David Nolan, Nicholas A Williamson, James McCluskey, 2008, Immunity.

Too much of a good thing: a retrospective study of &bgr;-lactam concentration–toxicity relationships

D. Marriott, H. Buscher, I. Sandaradura, 2017, The Journal of antimicrobial chemotherapy.

Post-Kala-Azar Dermal Leishmaniasis Due to Leishmania infantum in a Human Immunodeficiency Virus Type 1-Infected Patient

D. Stark, D. Marriott, J. Harkness, 2006, Journal of Clinical Microbiology.

Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose‐recommendation software

M. Baysari, R. Day, D. Marriott, 2020, British journal of clinical pharmacology.

Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis.

D. Cooper, D. Marriott, J. Harkness, 1991, AIDS.

Bordetella petrii from a clinical sample in Australia: isolation and molecular identification.

D. Stark, D. Marriott, J. Harkness, 2007, Journal of medical microbiology.

Lymphogranuloma venereum: an emerging anorectal disease in Australia

D. Stark, D. Marriott, J. Harkness, 2007, The Medical journal of Australia.

Lymphogranuloma Venereum in Australia: Anorectal Chlamydia trachomatis Serovar L2b in Men Who Have Sex with Men

D. Stark, S. V. van Hal, D. Marriott, 2007, Journal of Clinical Microbiology.

Description of Dientamoeba fragilis Cyst and Precystic Forms from Human Samples

D. Stark, D. Marriott, J. Harkness, 2014, Journal of Clinical Microbiology.

Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing

R. Day, D. Marriott, J. Carland, 2020, British journal of clinical pharmacology.

Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices.

Paul T. Williams, D. Marriott, J. Roberts, 2020, International journal of antimicrobial agents.

An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy

R. Day, D. Marriott, H. Buscher, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

D. Marriott, M. Neely, D. Cattaneo, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prevalence and significance of coagulase-negative staphylococci isolated from blood cultures in a tertiary hospital

D. Marriott, J. Harkness, S. Miyakis, 2008, Scandinavian Journal of Infectious Diseases.

The acquired immunodeficiency syndrome and tuberculosis

D. Marriott, J. Harkness, D. H. Bryant, 1988, Medical Journal of Australia.

Chronic cough in patients with HIV infection.

K. Wong, D. Cooper, D. Marriott, 1998, Scandinavian journal of infectious diseases.

Risk factors for candidaemia: A prospective multi‐centre case‐control study

D. Marriott, T. Sorrell, C. Keighley, 2020, Mycoses.

Non-susceptibility to ceftaroline in healthcare-associated multiresistant MRSA in Eastern Australia.

D. Marriott, J. Harkness, J. Iredell, 2015, The Journal of antimicrobial chemotherapy.

Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.

D. Marriott, T. Sorrell, E. McBryde, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package.

R. Day, D. Marriott, K. Williams, 2020, The Journal of antimicrobial chemotherapy.

False negative HIV-1 proviral DNA polymerase chain reaction in a patient with primary infection acquired in Thailand.

D. Marriott, C. Harris, D. Cooper, 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Whole Genome Sequencing of Australian Candida glabrata Isolates Reveals Genetic Diversity and Novel Sequence Types

D. Marriott, T. Sorrell, V. Sintchenko, 2018, Front. Microbiol..

Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases

D. Marriott, S. Kidd, A. Morris, 2019, Internal medicine journal.

Colonic malakoplakia in a dual stem cell and cardiac transplant recipient: A case report and literature review

P. Macdonald, C. Hayward, D. Marriott, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Fanconi syndrome due to tenofovir disoproxil fumarate reversed by switching to tenofovir alafenamide fumarate in an HIV-infected patient

D. Marriott, Jeffrey Masters, Nomvuyo Z. Mothobi, 2018, Therapeutic advances in infectious disease.

Disseminated Aspergillus lentulus infection in a heart transplant recipient: a case report.

K. Muthiah, P. Macdonald, D. Marriott, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Identification of Novel Hybrids Between Cryptococcusneoformans var. grubii VNI and Cryptococcusgattii VGII

D. Marriott, T. Sorrell, W. Meyer, 2012, Mycopathologia.

Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations

A. Blaxhult, B. Clotet, C. Kovacs, 2006, HIV clinical trials.

Multispecies Outbreak of Nocardia Infections in Heart Transplant Recipients and Association with Climate Conditions, Australia

A. Pitman, K. Muthiah, D. Marriott, 2022, Emerging infectious diseases.

Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy

R. Day, D. Marriott, I. Sandaradura, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Pasteurella ureae meningitis

D. Marriott, L. Brady, 1983, The Medical journal of Australia.

Assessment of cefepime toxico-dynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines.

D. Marriott, S. Wicha, J. Penm, 2021, International Journal of Antimicrobial Agents.

Amoebiasis: current status in Australia

D. Stark, D. Marriott, J. Ellis, 2007 .

HIV and autopsies

D. Marriott, Johan Duflou, 1996 .

Candidaemia and a risk predictive model for overall mortality: a prospective multicentre study

D. Marriott, T. Sorrell, C. Keighley, 2019, BMC Infectious Diseases.

Determinants of mortality in non-neutropenic ICU patients with candidaemia

D. Marriott, T. Sorrell, D. Ellis, 2009, Critical care.

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.

D. Marriott, T. Sorrell, V. Sintchenko, 2017, Journal of visualized experiments : JoVE.

Laryngeal cryptococcosis: Clinical presentation and treatment of a rare cause of hoarseness

D. Gordon, D. Marriott, H. M. Yapa, 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Identification of Novel Hybrids Between Cryptococcusneoformans var. grubii VNI and Cryptococcusgattii VGII

D. Marriott, T. Sorrell, W. Meyer, 2011, Mycopathologia.